glutamic acid has been researched along with zolmitriptan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alhalaweh, A; Bandiera, P; Beggiato, S; Dalpiaz, A; Ferraro, L; Gavini, E; Giunchedi, P; Marchetti, N; Rassu, G; Velaga, S | 1 |
Bansod, P; Swathi, KP; Tripathi, AS | 1 |
2 other study(ies) available for glutamic acid and zolmitriptan
Article | Year |
---|---|
Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Topics: Adhesives; Administration, Intranasal; Administration, Intravenous; Animals; Area Under Curve; Brain; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Glutamic Acid; Hypromellose Derivatives; Migraine Disorders; Nasal Mucosa; Oxazolidinones; Permeability; Polymers; Powders; Swine; Tryptamines | 2013 |
Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Models, Animal; Glutamic Acid; Glutathione; Glutathione Peroxidase; Maze Learning; Memory Disorders; Oxazolidinones; Oxidative Stress; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Scopolamine; Serotonin; Serotonin 5-HT1 Receptor Agonists; Superoxide Dismutase; Toll-Like Receptor 4; Tryptamines | 2021 |